Lung Cancer Alliance and a coalition of leading professional, government and non-governmental organizations joined the American Cancer Society to announce they will be coming together to form the National Lung Cancer Roundtable to accelerate the nation’s efforts to reduce mortality from lung cancer. The group will focus on ensuring those at high-risk for lung cancer have access to high-quality screening, while also working to ensure patients receive timely, patient-centered, state-of-the-art care for all stages of lung cancer. The coalition is supported by AstraZeneca.